Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma

Masahiro Kami, Tamae Hamaki, Shigesaburo Miyakoshi, Naoko Murashige, Yoshinobu Kanda, Ryuji Tanosaki, Yoichi Takaue, Shuichi Taniguchi, Hisamaru Hirai, Keiya Ozawa, Masaharu Kasai

Research output: Contribution to journalArticlepeer-review

83 Citations (Scopus)


The feasibility of allogeneic haematopoietic stem-cell transplantation (allo-HSCT) in 11 patients with adult T-cell leukaemia/lymphoma (ATL) (6 acute, 4 lymphoma, 1 chronic type) was evaluated. The preparative regimens (9 conventional, 2 reduced-intensity) were tolerable. Five patients developed acute graft-versus-host disease (GVHD), and three, extensive chronic GVHD. All 10 patients who survived > 30 d achieved complete remission. Estimated 1-year overall and disease-free survival rates were 53 ± 30% and 45 ± 29% respectively. Four patients remain alive and disease-free at a median follow-up of 25 months. The others died of transplantation-related complications. This pilot study suggests that allo-HSCT in ATL should be evaluated further.

Original languageEnglish
Pages (from-to)304-309
Number of pages6
JournalBritish Journal of Haematology
Issue number2
Publication statusPublished - 2003 Jan
Externally publishedYes


  • Adult T-cell leukaemia/lymphoma
  • Allogeneic haematopoietic stem-cell transplantation
  • Graft-versus-host disease
  • Graft-versus-leukaemia effect
  • Regimen-related toxicity

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma'. Together they form a unique fingerprint.

Cite this